MVZ Hämatologie und Onkologie Duisburg GmbH

What MVZ Hämatologie und Onkologie Duisburg GmbH does

MVZ Hämatologie und Onkologie Duisburg GmbH is a single-site outpatient specialist medical center (Medizinisches Versorgungszentrum) in Duisburg, Germany, providing diagnosis, therapy, and long-term aftercare for hematological and oncological diseases. The core services are oncology (chemotherapy, immunotherapy, antibody therapies, diagnostic and therapeutic punctures, bone marrow punctures) and hematology (clarification of abnormal blood counts, blood disorder treatment), supplemented by nutrition counseling as an integrated component of therapy and structured follow-up examinations. Patients access the practice via quarterly referral vouchers (Überweisungsschein) from general practitioners and specialists, and the center treats both statutory (GKV) and privately insured (PKV) patients under the Kassenärztliche Vereinigung Nordrhein framework.

The practice is a DKG-certified oncology center (cooperative certification with Ev. Krankenhaus Bethesda zu Duisburg, consecutively re-certified in 2022, 2023, and 2024) and additionally held a 2021 DKG Gynecological Center certification, with further cooperation links to two DKG-certified breast cancer centers. Operationally, the center employs four physicians (Medical Director Dr. med. Christian Saure, Deputy Dr. med. Christian Karbe, Dietmar Benzenberg, and specialist-in-training Dr. med. Anna Bartels) plus nursing, therapy, reception, and administrative staff, and is led by Managing Directors Bernd Rudloff and Dr. Guido Tuschen. In 2024 the practice deployed an AI-powered digital telephone assistant to handle inbound patient calls, capture structured intake information, and route requests to staff via SMS or callback.

The revenue model is fee-for-service under German statutory and private health insurance reimbursement schedules (EBM for GKV, GOÄ for PKV), with no disclosed subscription, premium, or productized offering. The entity operates as a private German GmbH under the sponsorship (Trägerschaft) of alanta med GmbH, a multi-site MVZ operator, which provides shared back-office and recruitment services (jobs.alanta-group.de). Marketing is limited to organic digital presence and the parent-group brand, with no paid acquisition channels identified.

Name

MVZ Hämatologie und Onkologie Duisburg GmbH

Legal name

MVZ Hämatologie und Onkologie Duisburg GmbH

Website

https://onkologieduisburg.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

MVZ Hämatologie und Onkologie Duisburg GmbH is a single-site, DKG-certified outpatient hematology and oncology medical center in Duisburg, Germany, serving statutory and privately insured patients referred by GPs and specialists for cancer and blood disorder treatment, aftercare, and nutrition counseling.

Ownership category

akta.pro rank

Product category

Outpatient Oncology and Hematology Services

NAICS

Offices of Physicians (62111), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAA

Medical Hematology (Benign Hematology)

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Outpatient oncology care
• Hematology services
• Medical care center
• Cancer treatment services
• Chemotherapy infusion therapy

Headquarters

HQ city

Duisburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Statutory Health Insurance (Gesetzliche Krankenversicherung): The MVZ operates as a contracted care provider with the statutory health insurance system (Kassenärztliche Versorgung). Patients require a valid referral voucher (Überweisungsschein) issued by their general practitioner or specialist, valid for each quarter (Jan-Mar, Apr-Jun, Jul-Sep, Oct-Dec). The practice also treats privately insured patients.
2. Private Health Insurance (Private Krankenversicherung): The practice also serves privately insured patients, billing directly according to the German fee schedule for physicians (GOÄ).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

The MVZ Hämatologie und Onkologie Duisburg GmbH operates as an outpatient medical care center (Medizinisches Versorgungszentrum) providing specialist hematology and oncology services to patients in Duisburg, Germany. It plans and delivers individualized therapy programs including chemotherapy, immunotherapy, antibody therapies, diagnostic and therapeutic punctures, bone marrow punctures, and long-term aftercare, supported by nutritional counseling and a recently introduced AI-powered digital phone assistant.

Product overview

MVZ Hämatologie und Onkologie Duisburg GmbH operates as a certified oncology center providing outpatient hematological and oncological therapy services. The practice offers two core service lines: Oncology Services (for cancer patients) and Hematology Services (for blood disorders), both planned and managed based on the latest medical findings and guidelines. These core services are supported by complementary offerings including Nutritional Counseling as an integral part of therapy, and Follow-up Examinations for long-term patient monitoring after treatment completion. The practice also recently introduced a Digital Phone Assistant to improve patient accessibility. The practice functions as a single unified healthcare facility rather than a platform-plus-modules architecture.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Services
• Hematology Services
• Digital Phone Assistant

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• alanta med GmbHcoreOthers · 1 January 2024The MVZ Hämatologie und Onkologie Duisburg GmbH is under the sponsorship/trusteeship (Trägerschaft) of alanta med GmbH. alanta med GmbH is a healthcare company operating multiple medical care centers (MVZ) in Germany. The MVZ appears under the alanta group of companies and recruits staff through the alanta group's recruitment channels.
• Ev. Krankenhaus Bethesda zu DuisburgcoreStrategic or Co-development PartnerThe MVZ operates as a Certified Oncology Center (Zertifiziertes Onkologisches Zentrum) in cooperation with Ev. Krankenhaus Bethesda zu Duisburg, certified by Deutsche Krebsgesellschaft e.V. (DKG). The partnership ensures seamless coordination between outpatient and inpatient care for oncology patients.
• Brustkrebszentrum BETHESDAminorStrategic or Co-development PartnerBreast cancer center (Brustkrebszentrum) at Ev. Krankenhaus Bethesda in Duisburg. The MVZ cooperates with this certified breast cancer center as part of the oncology network.
• Brustkrebszentrum Helios St. Anna DuisburgminorStrategic or Co-development PartnerBreast cancer center at Helios St. Anna Hospital in Duisburg. The MVZ cooperates with this certified breast cancer center as part of the oncology care network.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Asklepios Kliniken GmbH: Major German private hospital operator with oncology programs across multiple sites. Competes for hematology/oncology referrals and shares the same statutory payer environment as the subject.
• Sana Kliniken AG: Large German private hospital group with hematology/oncology departments and outpatient structures. Broad incumbent in the same regulatory environment with overlapping DKG-certified center activity.
• Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und Klinische Immunologie: University hospital hematology/oncology department where subject physicians previously trained. Competes for complex cases and clinical trial referrals in the same North Rhine-Westphalia catchment but operates as a broader academic incumbent.
• Helios Klinikum Duisburg: Major German private hospital group operating in Duisburg with a Brustkrebszentrum. Overlaps with the subject on outpatient oncology referrals and serves as both a partner (cooperation agreement) and a broader incumbent competing for complex cancer cases in the same catchment.

Direct peers

• OnkoZentrum / Onkologische Praxisgemeinschaft (e.g., Oncologikum Frankfurt, MVZ Porta Westfalica): Representative category of German MVZs/Praxisgemeinschaften offering outpatient hematology and oncology under KV contracts. Comparable size, service mix, and DKG certification profile.
• Evangelisches Krankenhaus Bethesda Duisburg: Cooperation partner for the DKG-certified oncology center and operator of an inpatient hematology/oncology program. Comparable in scope (hematology + oncology, Duisburg, certified) and serves the same patient population across the inpatient/outpatient boundary.
• Onkozentrum Dresden / Onkologische Schwerpunktpraxis (representative German outpatient oncology MVZ): Representative of the broader category of German outpatient hematology/oncology specialist practices (Schwerpunktpraxis) that deliver chemotherapy, immunotherapy and supportive care under KV contracts. Directly comparable business model, scale and reimbursement environment.
• MVZ Onkologie / Hämatologie practices under alanta med GmbH (sibling sites): Other outpatient oncology and hematology MVZs operated by the same parent company, alanta med GmbH. They share the same operating model, DKG certification pathway, GKV billing structure, and central support functions, making them the closest operational comparables.
• Medicover Hämatologie / Onkologie MVZs (Germany): European operator of outpatient specialist MVZs including hematology/oncology sites in Germany. Comparable operating model (KV-billed outpatient cancer care, multi-site roll-up strategy) and represents a scaled version of the subject's growth trajectory.

Emerging players

• GenesisCare (Germany operations): International outpatient oncology operator with German sites focused on radiotherapy and medical oncology. Comparable outpatient delivery model and emerging as a scaled regional oncology competitor in Germany.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mvz-h%C3%A4matologie-und-onkologie-duisburg-gmbh

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MVZ Hämatologie und Onkologie Duisburg GmbH